Efficacy and safety of formoterol certihaler tiotropium handihaler and tiotropium handihaler in combination with formoterol certihaler in patients with stable chronic obstructive pulmonary disease.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2011
At a glance
- Drugs Formoterol; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Novartis
- 24 Oct 2011 Actual end date (November 2005) added as reported by ClinicalTrials.gov.
- 24 Oct 2011 Company Pacira Pharmaceuticals added to the associations filed as reported by ClinicalTrials.gov record.
- 24 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History